Filing Flows

Filing Flows › Taysha Gene Therapies (TSHA) › Who owns the stock

Who owns Taysha Gene Therapies (TSHA) stock

198 funds reported Taysha Gene Therapies (TSHA) shares in their latest 13F filings, worth $2.1B in all. The largest holder is Avoro Capital Advisors LLC ($163M). Last quarter 126 funds added to their stakes and 63 cut them.

Largest holders of TSHA (13F)Largest holders of TSHA (13F)Avoro Capital Advisors LLC$163MRA Capital Management, L.P.$160MGoldman Sachs Group$155MBlackRock$141MVestal Point Capital, LP$132MMorgan Stanley$112MRTW Investments, LP$92.3MFMR LLC$90.8MVanguard Capital Management LLC$85.0MState Street$77.8M

Largest holders (13F)

FundSharesValueChangeQuarter
Avoro Capital Advisors LLC23,888,888$163Mincrease2026-06-30
RA Capital Management, L.P.23,555,648$160Munchanged2026-06-30
Goldman Sachs Group22,713,118$155Mincrease2026-06-30
BlackRock20,691,927$141Mincrease2026-06-30
Vestal Point Capital, LP19,415,000$132Mincrease2026-06-30
Morgan Stanley16,487,479$112Mdecrease2026-06-30
RTW Investments, LP13,560,258$92.3Mdecrease2026-06-30
FMR LLC13,336,413$90.8Mdecrease2026-06-30
Vanguard Capital Management LLC12,478,595$85.0Mincrease2026-06-30
State Street11,421,920$77.8Mincrease2026-06-30
Vanguard Group13,267,805$73.0Mincrease2025-12-31
Siren, L.L.C.9,846,579$67.1Mincrease2026-06-30
Octagon Capital Advisors LP9,693,244$66.0Mincrease2026-06-30
Geode Capital Management, LLC6,560,394$44.7Mincrease2026-06-30
Polar Capital Holdings5,117,133$34.8Mdecrease2026-06-30

Taysha Gene Therapies' latest quarter

Taysha Gene Therapies, Q4 2025: revenue $5.5M (+171% year over year), operating margin -516.0%, net loss $27.9M, operating cash flow −$26.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most TSHA stock?

By the latest 13F filings: Avoro Capital Advisors LLC ($163M); RA Capital Management, L.P. ($160M); Goldman Sachs Group ($155M); BlackRock ($141M); Vestal Point Capital, LP ($132M).

What is the short interest in TSHA?

51,249,292 shares were sold short at the 2026-10-15 settlement, -6.85% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.